Niagen Bioscience Inc (NAGE) Earnings History
Profitable19 years of earnings data (2007–2025) · Positive TTM net income
Loading earnings history...
Niagen Bioscience Inc (NAGE) Earnings Overview
As of June 28, 2026, Niagen Bioscience Inc (NAGE) reported trailing twelve-month net income of $19M, reflecting +81.8% year-over-year growth. The company earned $0.22 per diluted share over the past four quarters, with a net profit margin of 13.4%.
Looking at the long-term picture, NAGE's historical earnings data spans multiple years. The company achieved its highest annual net income of $17M in fiscal 2025, representing a new all-time high.
Niagen Bioscience Inc maintains positive profitability with a gross margin of 64.3%, operating margin of 11.0%, and net margin of 13.4%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including NRXP (-$25M net income, -2336.5% margin), HALO ($349M net income, 22.7% margin), NBIX ($669M net income, 16.7% margin), NAGE has outperformed on profitability metrics. Compare NAGE vs NRXP →
NAGE Earnings vs Peers
Earnings metrics vs comparable public companies
NAGE Historical Earnings Data (2007–2025)
19 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $17M | +103.3% | $14M | $0.20 | 13.4% | 11.0% |
| 2024 | $9M | +273.1% | $8M | $0.11 | 8.6% | 7.8% |
| 2023 | -$5M | +70.1% | -$6M | $-0.07 | -5.9% | -6.7% |
| 2022 | -$17M | +39.0% | -$19M | $-0.24 | -23.0% | -25.9% |
| 2021 | -$27M | -36.2% | -$27M | $-0.40 | -40.2% | -40.1% |
| 2020 | -$20M | +38.0% | -$20M | $-0.33 | -33.6% | -33.5% |
| 2019 | -$32M | +3.5% | -$31M | $-0.56 | -69.4% | -67.6% |
| 2018 | -$33M | -192.8% | -$33M | $-0.61 | -105.6% | -105.1% |
| 2017 | -$11M | -288.6% | -$16M | $-0.26 | -53.7% | -77.2% |
| 2016 | -$3M | -5.7% | -$3M | $-0.08 | -13.5% | -13.4% |
| 2015 | -$3M | +48.6% | -$2M | $-0.08 | -15.5% | -11.6% |
| 2014 | -$5M | -21.9% | -$5M | $-0.15 | -35.2% | -34.2% |
| 2013 | -$4M | +62.1% | -$4M | $-0.13 | -43.5% | -43.2% |
| 2012 | -$12M | -47.7% | -$12M | $-0.36 | -100.4% | -100.2% |
| 2011 | -$8M | -284.8% | -$8M | $-0.35 | -97.3% | -96.9% |
| 2010 | -$2M | -126.1% | -$2M | $-0.13 | -27.1% | -26.7% |
| 2009 | $-907,568 | +56.9% | $-892,732 | $-0.09 | -15.7% | -15.5% |
| 2008 | -$2M | -5383.0% | -$2M | $-0.22 | -46.7% | -45.8% |
| 2007 | $-38,382 | - | $-38,382 | $-0.01 | - | - |
Download Data
Export NAGE earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
19+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
NAGE — Frequently Asked Questions
Quick answers to the most common questions about buying NAGE stock.
What is NAGE earnings per share (EPS)?
NAGE trailing twelve-month (TTM) diluted EPS is $0.22, reflecting +81.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2007 to 2025 is available in the table on this page.
What is Niagen Bioscience Inc's net income?
Niagen Bioscience Inc (NAGE) trailing twelve-month net income is $19M as of 2025. Earnings grew +81.8% year-over-year. Niagen Bioscience Inc has been profitable for 2 consecutive years.
Is NAGE profitable?
Yes, NAGE is profitable with a TTM net income of $19M and a net profit margin of +13.4%. Niagen Bioscience Inc has generated profits for 2 consecutive years.
What is NAGE's earnings growth rate?
NAGE compound annual EPS growth rates (CAGR): 1-Year: +81.8%, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2007 to 2025.
What are NAGE's profit margins?
Niagen Bioscience Inc net profit margin is +13.4%, operating margin is +11.0%, and gross margin is +64.3%. Margins are within a typical range for the sector. Return on Equity is +28.3%.
Is NAGE growing earnings?
Yes, NAGE earnings are accelerating — EPS growth of +81.8% exceeds the 5-year CAGR of N/A. TTM net income reached $19M. Earnings momentum is strengthening.
What was NAGE's best earnings year?
Niagen Bioscience Inc's highest annual net income on record is $17M, achieved in fiscal year 2025. Earnings history on this page spans 2007 to 2025 and includes all annual and quarterly figures.
What were NAGE's earnings last quarter?
NAGE's most recent reported quarter was Q1 2026. Net income was $6M with diluted EPS of $0.07. For a full breakdown of all quarters, see the quarterly earnings table on this page.